**Core Concept**
Dapsone is a sulfone antibiotic and antimetabolite used in the treatment of leprosy, dermatitis herpetiformis, and certain types of malaria. Its mechanism of action involves the inhibition of dihydropteroate synthase, an enzyme crucial for the synthesis of tetrahydrofolate.

**Why the Correct Answer is Right**
Dapsone works by competitively inhibiting dihydropteroate synthase, which is necessary for the biosynthesis of tetrahydrofolate, a critical cofactor in the synthesis of purines and pyrimidines. This inhibition leads to the disruption of nucleic acid synthesis in susceptible microorganisms. Additionally, dapsone has been shown to have immunomodulatory effects, which contribute to its therapeutic efficacy in autoimmune diseases like dermatitis herpetiformis.

**Why Each Wrong Option is Incorrect**
**Option A:** Dapsone is known to cause hemolysis in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency, but this is not a statement regarding dapsone's mechanism of action or properties.
**Option B:** Dapsone is indeed used in the treatment of leprosy and dermatitis herpetiformis, making this statement true but not relevant to the question.
**Option C:** There is no evidence to suggest that dapsone is a direct inhibitor of dihydrofolate reductase (DHFR), an enzyme involved in the synthesis of tetrahydrofolate. DHFR is indeed targeted by other antimetabolites like methotrexate.

**Clinical Pearl / High-Yield Fact**
It is essential to remember that dapsone can cause a range of adverse effects, including hemolysis, methemoglobinemia, and agranulocytosis. Patients should be monitored closely for these potential complications, especially in the context of pre-existing medical conditions like G6PD deficiency.

**Correct Answer:** C.